Skip to main content
Log in

Systemic Candida infection in University Hospital 1997–1999: the distribution of Candida biotypes and antifungal susceptibility patterns

  • Published:
Mycopathologia Aims and scope Submit manuscript

Abstract

A total of 102 Candida species were isolated from blood cultures from January 1997 to October 1999. Using assimilation of carbohydrate test, 52 (51.0%) of the Candida sp. were identified as C. parapsilosis, 25.5% (26) were C. tropicalis. C. albicans made up 11.8% (12), 6.9% (7) were C. rugosa, 3.8% (4) C. glabrata and 1% (1) C. guilliermondii. No C. dubliniensis was found in the study. In vitro antifungal susceptibility tests showed that all Candida species were sensitive to nystatin, amphotericin B and ketoconazole. Although all isolates remained sensitive to fluconazole, intermediate susceptibility was found in 3 C. rugosa isolates. Antifungal agents with high frequency of resistance were econazole, clotrimazole, miconazole and 5-fluorocytosine. Candida species found to have resistance to these antifungal agents were non-C. albicans.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Jarvis WR. Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin Infect Dis 1995; 20: 1526-1530.

    PubMed  CAS  Google Scholar 

  2. Kossoff EH, Buescher ES, Karlowicz MG. Candidemia in a neonatal intensive care unit: trends during fifteen years and clinical features of 111 cases. Pediatr Infect Dis J 1998; 17(6): 504-508.

    Article  PubMed  CAS  Google Scholar 

  3. Sasse KC, Nauenberg E, Long A, Anton B, Tucker HJ, Hu TW. Long term survival after intensive care unit admission with sepsis. Crit Care Med 1995; 23: 1040-1047.

    Article  PubMed  CAS  Google Scholar 

  4. Wey, SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP. Risk factors for hospital-acquired candidemia. A matched case-control study. Arch Intern Med 1989; 149: 2349-2353.

    Article  PubMed  CAS  Google Scholar 

  5. Ng KP, Madasamy M, Saw TL, Baki A, He J, Soo-Hoo TS. Candida biotypes isolated from clinical specimens in Malaysia. Mycopathologia 1999; 144: 135-140.

    Article  CAS  Google Scholar 

  6. Chakrabarti A, Chander J, Kasturi P, Panigrahi D. Candidaemia: a 10-year study in an Indian teaching hospital. Mycoses 1992; 35(1-2): 47-51.

    Article  PubMed  CAS  Google Scholar 

  7. Krcmery V Jr, Spanik S, Grausova S, Trupl J, Krupova I, Roidova A, Salek T, Sufliarsky J, Mardiak J. Candida parapsilosis fungemia in cancer patients-incidence, risk factors and outcome. Neoplasma 1998; 45(5): 336-342.

    PubMed  CAS  Google Scholar 

  8. Levy I, Rubin LG, Vasishtha S, Tucci V, Sood SK. Emergence of Candida parapsilosis as the predominant species causing candidemia in children. Clin Infect Dis 1998; 26(5): 1086-1088.

    PubMed  CAS  Google Scholar 

  9. Abi-Said D, Anaissie E, Uzun O, Raad I, Pinzcowski H, Vartivarian S. The epidemiology of hematogenous candidiasis caused by different Candida species. Clin Infect Dis 1997; 24(6): 1122-1128.

    PubMed  CAS  Google Scholar 

  10. Weinberger M, Sacks T, Sulkes J, Shapiro M, Polacheck I. Increasing fungal isolation from clinical specimens: experience in a university hospital over a decade. J Hosp Infect 1997; 35(3): 185-195.

    Article  PubMed  CAS  Google Scholar 

  11. Voss A, le Boble JL, Verduyn Lunel FM, Foudraine NA, Meis JF. Candidemia in intensive care unit patients: risk factors for mortality. Infection 1997; 25(1): 8-11.

    Article  PubMed  CAS  Google Scholar 

  12. Nguyen MH, Peacock JE Jr, Morris AJ, Tanner DC, Nguyen ML, Snydman DR, Wagener NM, Rinaldi MG, Yu VL. The changing face of candidemia: emergence of non-Candidia albicans species and antifungal resistance.Am J Med 1996; 100(6): 617-623.

    Article  PubMed  CAS  Google Scholar 

  13. Kiehn TE, Edwards FF, Armstrong D. The prevalence of yeasts in clinical specimens from cancer patients. Am J Clin Pathol 1980; 73(4): 518-521.

    PubMed  CAS  Google Scholar 

  14. Merz WG, Karp JE, Schron D, Saral R. Increased incidence of fungemia caused by Candida krusei. J Clin Microbiol 1986; 24(4): 581-584.

    PubMed  CAS  Google Scholar 

  15. Abrahamsen TG, Widing E, Glomstein A, Gaustad P. Disseminated fungal disease resistant to fluconazole treatment in a child with leukaemia. Scand J Infect Dis 1992; 24: 391-393.

    PubMed  CAS  Google Scholar 

  16. Krcmery V Jr, Oravcova E, Spanik S, Mrazova-Studena M, Trupi J, Kunova A, Stopkova-Grey K, Kuikuckova E, Krupova I, Demitrovicova A, Kralovicova K. Nosocomial breakthrough fungaemia during antifungal prophylaxis or empirical antifungal therapy in 41 cancer patients receiving antineoplastic chemotherapy: analysis of aetiology risk factors and outcome. J Antimicrob Chemother 1999; 41(3): 373-380.

    Article  Google Scholar 

  17. Nolte FS, Parkinson T, Falconer DJ, Dix S, Williams J, Gilmore C, Geller R, Wingard JR. Isolation and characterization of fluconazole-and amphotericin B resistant Candida albicans from blood of two patients with leukaemia. Antimicrob Agents Chemother 1997; 41(1): 196-199.

    PubMed  CAS  Google Scholar 

  18. Sandford GR, Merz WG, Wingard JR, Charache P, Saral R. The value of fungal surveillance cultures as predictors of systemic infections. J Infect Dis 1980; 142: 503-509.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ng, K., Saw, T., Na, S. et al. Systemic Candida infection in University Hospital 1997–1999: the distribution of Candida biotypes and antifungal susceptibility patterns. Mycopathologia 149, 141–146 (2001). https://doi.org/10.1023/A:1007283211220

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1007283211220

Navigation